FirsthandHealth
medRxiv PreprintsInternational20 November 2026

UV-induced Mutations are Associated with Melanoma-Specific Mortality in Stage II/III Melanomas from the InterMEL study

This is an official announcement record

Firsthand records what medRxiv Preprints announced and links to the original. The wording below is theirs, not ours.

The prognostic significance of tumor mutational burden (TMB) in melanoma remains controversial. One potential reason for the mixed results is that total TMB treats all mutations as biologically equivalent, despite evidence that different types of mutations contribute differently to a tumor's neo-antigenic profile. In particular, UV-induced and non-UV mutations may have distinct effects on tumor behavior and outcomes, but this hypothesis has been studied primarily in advanced-stage disease. We analyzed 656 stage II/III tumors from the InterMEL study to evaluate whether UV TMB and non-UV TMB are
Source: medRxiv Preprints
Read the official announcement

Opens www.medrxiv.org

More from medRxiv Preprints

This content is for informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease. Consult a healthcare professional before starting any supplement, treatment, or program: especially if you are pregnant, nursing, taking medication, or managing a health condition.